Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FWCRZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,225
Award facts
- Contract value 100% obligated
- $14,224.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 ml pen injections with a ceiling value of $14,224.59 under a firm fixed-price contract type. The award was made on September 23, 2025, with an ultimate completion date of September 24, 2025, and does not utilize a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. The place of performance is located at the company's corporate office in Conshohocken, PA.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. DUPIXENT is a biologic medication used to treat conditions such as atopic dermatitis and asthma, and this procurement supports the Defense Health Agency and other federal healthcare systems in maintaining adequate supplies of specialty medications required for beneficiary care.
Quick answers
Who was awarded contract SPE2DB25FWCRZ?
SPE2DB25FWCRZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FWCRZ worth?
The government has obligated $14,225 on SPE2DB25FWCRZ.
Is contract SPE2DB25FWCRZ an order under another contract?
Yes. SPE2DB25FWCRZ is a delivery order under SPE2DB25D3022, an indefinite delivery contract.
Was contract SPE2DB25FWCRZ competed?
The extent of competition for SPE2DB25FWCRZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award